Christine Schwall-Pecci

Christine Schwall-Pecci, PhD, is currently the Senior Vice President, Medical Director, Medical Strategy & Scientific Affairs at BGB Group. Christine has a diverse background in cardiology, oncology, women's health, biosimilars, and various medical writing experiences. Prior to their current role, Christine held positions at Icahn School of Medicine at Mount Sinai, where Christine managed programmatic oversight, and at the University of Connecticut where Christine conducted research in Biochemistry. Christine has a Ph.D. in Biochemistry from the University of Connecticut and a Bachelor of Science in Biology from Fordham University with minors in Chemistry and Sociology.